Advisory: Alerts on Genmab, Tempus entering into strategic collaboration agreement withdrawn
Sept 9 (Reuters) - Please ignore alerts on Tempus entering
into strategic collaboration agreement with Genmab as they were
sent in error from a press release of an unrelated company.
STORY_NUMBER: FWN2600K5
STORY_DATE: 09/09/2019
STORY_TIME: 01:08:01
((gdynia.newsroom@thomsonreuters.com; +48 58 772 07 02;))
Recent news on Tempus Holdings
See all newsFactbox: Chinese tech firms, from Apple suppliers to OpenAI rivals, raise $20 billion in Hong Kong
Factbox: Chinese tech firms, from Apple suppliers to OpenAI rivals, raise $17 billion in Hong Kong
Press Digest: Wall Street Journal - July 8
China's Momenta debuts flat in Hong Kong as IPO caution grips AI listings (updated)
Chinese autonomous driving firm Momenta set to open slightly higher in Hong Kong debut